AnalystsBill MaughanBill Maughan's Stock Forecasts
AnalystsBill Maughan
Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4577 out of 5014 analysts
Average Return
-36.02%
Win Rate
22%2 out of 9
Risk vs Reward
Poor
Good
Bill Maughan Analyst Color
Get additional color on Bill Maughan's coverage of popular stocks
Bill Maughan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Y Mabs Therapeutics IncYMAB | 3 | Hold | $8.60 | +0.12% | Downgrades | a month ago |
Krystal Biotech IncKRYS | 1 | Strong Buy | $190.00 | +32.24% | Initiates Coverage On | 2 months ago |
Crispr Therapeutics AgCRSP | 1 | Hold | $45.00 | -20.01% | Downgrades | 3 months ago |
Nkarta IncNKTX | 2 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Fate Therapeutics IncFATE | 1 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
Immunocore Holdings PLCIMCR | 3 | Hold | $67.00 | N/A | Maintains | a year ago |
Moderna IncMRNA | 3 | Hold | $106.00 | N/A | Maintains | a year ago |
Century Therapeutics IncIPSC | 1 | Strong Buy | $24.00 | N/A | Maintains | a year ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $60.00 | N/A | Reiterates | 2 years ago |
Merus NvMRUS | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.